Secondary Logo

Journal Logo

May 1, 2019 - Volume 33 - Issue 6
pp: 931-1103

Minority and majority pretreatment HIV-1 drug resistance associated with failure of first-line nonnucleoside reverse-transcriptase inhibitor antiretroviral therapy in Kenyan women

Milne, Ross S.; Silverman, Rachel A.; Beck, Ingrid A.; More

AIDS. 33(6):941-951, May 1, 2019.

Impact of HIV/simian immunodeficiency virus infection and viral proteins on adipose tissue fibrosis and adipogenesis

Gorwood, Jennifer; Bourgeois, Christine; Mantecon, Matthieu; More

AIDS. 33(6):953-964, May 1, 2019.

Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HIV-associated neurocognitive disorders in EcoHIV-infected mice

Kim, Boe-Hyun; Kelschenbach, Jennifer; Borjabad, Alejandra; More

AIDS. 33(6):973-984, May 1, 2019.

Epstein–Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era

Lupo, Julien; Germi, Raphaële; Lancar, Rémi; More

AIDS. 33(6):993-1000, May 1, 2019.

Distinct gut microbiota profile in antiretroviral therapy-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers

Sessa, Libera; Reddel, Sofia; Manno, Emma; More

AIDS. 33(6):1001-1011, May 1, 2019.

Trends in cause-specific mortality in HIV–hepatitis C coinfection following hepatitis C treatment scale-up

Kronfli, Nadine; Bhatnagar, Sahir R.; Hull, Mark W.; More

AIDS. 33(6):1013-1022, May 1, 2019.

Work and home productivity of people living with HIV in Zambia and South Africa

Thomas, Ranjeeta; Friebel, Rocco; Barker, Kerrie; More

AIDS. 33(6):1063-1071, May 1, 2019.

Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana

Moyo, Sikhulile; Gaseitsiwe, Simani; Zahralban-Steele, Melissa; More

AIDS. 33(6):1073-1082, May 1, 2019.